Is it time to rethink Dyson Spheres?

The firm went public on Nasdaq in 2020.

 This new type of “nanosyringe” can attach to human cells and inject customized proteins into them.a new advancement uses bacterial “nanosyringes” to deliver protein payloads into individual human tissues and cells.

 The breakthrough could pave the way for the development of more effective treatments for a variety of diseases.“I think it substantiates protein engineering as a useful tool in bioengineering and the development of new therapeutic systems.Initial results suggest that it could be used to help deliver treatments directly into human cells in the future.

See Also Nanosyringes to target individual cellsThe study is led by researchers from MIT’s McGovern Institute for Brain Research and the Broad Institute.” which can naturally bind to insect cells and inject a protein payload into them to kill them.

Our results demonstrate that PVCs are programmable protein delivery devices with possible applications in gene therapy.

Study Abstract:Endosymbiotic bacteria have evolved intricate delivery systems that enable these organisms to interface with host biology.See Also An explosive space station module testColorado-based Sierra Space announced on Wednesday that it had blown up the last of its prototype modules designated for its explosive test campaign.

Sierra Space and Blue Origin have previously stated that they aim to launch their space station to orbit by around 2027.Sierra Space announced that it will begin testing full-scale LIFE habitat prototypes later this year.

Sierra Space aims to eventually carry astronauts to the Orbital Reef station using its in-development Dream Chaser spacecraft.NASA announced three contracts totaling $415 million for private space firms to develop US-operated successors to the ISS.